André Larente
Tracked across 7 events · 48 articles · First seen Apr 08, 2026 · Last active Aug 13, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: André Larente, CEO of Diagnosis, will be presenting at the conference, representing the company and interacting with investors.
Jun 03, 2026 · 8 articles
Regulatory
Impact: André Larente, CEO of Diagnosis, is leading the company's efforts to advance CARA through regulatory processes and prepare for commercialization.
Apr 08, 2026 · 6 articles
Regulatory
On August 13, 2026, Diagnosis Inc., a Canadian company specializing in AI-based early detection of eye diseases, announced that it received Medical Device Marketing Authorization for its CARA System from the Saudi Arabia — Saudi…
Impact: André Larente, CEO of Diagnosis, commented on the approval, emphasizing its importance for expanding sales beyond North America. His leadership is relevant to the company's strategy.
Aug 13, 2026 · 6 articles
Business
Impact: André Larente is the President of Diagnosis and a contact person for further information regarding the company's announcements.
Jun 12, 2026 · 9 articles
Regulatory
Impact: André Larente is President and CEO of Diagnosis, commented on the achievement.
Jul 27, 2026 · 6 articles
Business
Impact: André Larente is the President of Diagnosis and a contact person for further information regarding the debt settlement.
Jun 18, 2026 · 6 articles
Business
Impact: André Larente is the President of Diagnosis and the contact person for the announcement.
Jul 07, 2026 · 7 articles
ERGEN INTELLIGENCE
Track André Larente live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard